Disclosed i s a composition w c 1 can accelerate the production o f adiponectin, i s not problematic in terms o f safety issues such a s side effects o r toxicity, and can b e orally administered. The adiponectin production accelerating composi 0 tion, which has the effect o f accelerating adiponectin production, contains salmon milt ex 0 tract, brewers yeast extract, avian collagen and mineral containing yeast. I t i s preferable that the 0 salmon milt extract contains low-molecular compo nents broken u p as far a s olignucleotides and 0 oligopeptides b y enzyme treating salmon milt. I t i s 0 preferable that the brewers yeast extract contains 50- 80% RNA. I t i s preferable that the mineral con 0 taining yeast contains 0.0 1-0.02% selenium, 0.3-0.5% copper and 2-3% zinc in dry yeast. Fur thermore, i t i s preferable that 16-17 parts b y mass o f the brewers yeast extract, 33-34 parts b y mass o f the avian collagen, and 22-23 parts b y mass o f the mineral containing yeast are included per 100 parts A A adipinectin protein release (% ot control) b y mass o f the salmon milt extract. B B control
